Skip to main content

DOD Translational Team Science Award, a new grant, funded!

Posted by on Friday, June 21, 2024 in Uncategorized.

We will determine if we can predict the ability of pyrvinium to reprogram the gastric mucosa using patient-derived pre-cancer organoids.  Also, we will initiate a clinical trial to evaluate the ability of a 2-week treatment with pyrvinium to reprogram metaplasia in a high-risk diverse population at Duke University in North Carolina.

Grant funds research for therapies to prevent stomach cancer

 

 

Leave a Response